264 related articles for article (PubMed ID: 8855783)
21. Seasonal variation of biochemical indexes of bone turnover: results of a population-based study.
Woitge HW; Scheidt-Nave C; Kissling C; Leidig-Bruckner G; Meyer K; Grauer A; Scharla SH; Ziegler R; Seibel MJ
J Clin Endocrinol Metab; 1998 Jan; 83(1):68-75. PubMed ID: 9435418
[TBL] [Abstract][Full Text] [Related]
22. Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis.
Garnero P; Sornay-Rendu E; Chapuy MC; Delmas PD
J Bone Miner Res; 1996 Mar; 11(3):337-49. PubMed ID: 8852944
[TBL] [Abstract][Full Text] [Related]
23. Circulating levels of interleukin-6 soluble receptor predict rates of bone loss in patients with primary hyperparathyroidism.
Nakchbandi IA; Mitnick MA; Lang R; Gundberg C; Kinder B; Insogna K
J Clin Endocrinol Metab; 2002 Nov; 87(11):4946-51. PubMed ID: 12414855
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of bone loss and the serum markers of bone metabolism in patients with hyperparathyroidism.
Katagiri M; Ohtawa T; Fukunaga M; Harada T
Surg Today; 1995; 25(7):598-604. PubMed ID: 7549270
[TBL] [Abstract][Full Text] [Related]
25. Clinical profile of 128 subjects operated for primary hyperparathyroidism.
Haddock L; Aguiló F; Vázquez Quintana E; Vázquez MC; Rabell V; Allende M
P R Health Sci J; 1998 Dec; 17(4):309-16. PubMed ID: 10028537
[TBL] [Abstract][Full Text] [Related]
26. [Markers of bone formation and resorption in primary and secondary hyperparathyroidism].
Kosowicz J; Baszko-Błaszyk D; Horst-Sikorska W; Ruszkowska J
Pol Arch Med Wewn; 1998 Apr; 99(4):287-97. PubMed ID: 9760816
[TBL] [Abstract][Full Text] [Related]
27. Serum BAP as the clinically useful marker for predicting BMD reduction in diabetic hemodialysis patients with low PTH.
Ueda M; Inaba M; Okuno S; Maeno Y; Ishimura E; Yamakawa T; Nishizawa Y
Life Sci; 2005 Jul; 77(10):1130-9. PubMed ID: 15978265
[TBL] [Abstract][Full Text] [Related]
28. Circulating cytokine levels in osteoporotic and normal women.
Khosla S; Peterson JM; Egan K; Jones JD; Riggs BL
J Clin Endocrinol Metab; 1994 Sep; 79(3):707-11. PubMed ID: 8077350
[TBL] [Abstract][Full Text] [Related]
29. Effects of short-term recombinant human insulin-like growth factor I administration on bone turnover in osteopenic women with anorexia nervosa.
Grinspoon S; Baum H; Lee K; Anderson E; Herzog D; Klibanski A
J Clin Endocrinol Metab; 1996 Nov; 81(11):3864-70. PubMed ID: 8923830
[TBL] [Abstract][Full Text] [Related]
30. Longitudinal changes in bone mineral density and bone turnover in postmenopausal women with primary hyperparathyroidism.
Guo CY; Thomas WE; al-Dehaimi AW; Assiri AM; Eastell R
J Clin Endocrinol Metab; 1996 Oct; 81(10):3487-91. PubMed ID: 8855790
[TBL] [Abstract][Full Text] [Related]
31. Femoral neck osteopenia in patients with inflammatory bowel disease.
Pollak RD; Karmeli F; Eliakim R; Ackerman Z; Tabb K; Rachmilewitz D
Am J Gastroenterol; 1998 Sep; 93(9):1483-90. PubMed ID: 9732930
[TBL] [Abstract][Full Text] [Related]
32. Skeletal changes in osteoprotegerin and receptor activator of nuclear factor-kappab ligand mRNA levels in primary hyperparathyroidism: effect of parathyroidectomy and association with bone metabolism.
Stilgren LS; Rettmer E; Eriksen EF; Hegedüs L; Beck-Nielsen H; Abrahamsen B
Bone; 2004 Jul; 35(1):256-65. PubMed ID: 15207766
[TBL] [Abstract][Full Text] [Related]
33. Influence of the selective oestrogen receptor modulator (raloxifene hydrochloride) on IL-6, TNF-alpha, TGF-beta1 and bone turnover markers in the treatment of postmenopausal osteoporosis.
Ozmen B; Kirmaz C; Aydin K; Kafesciler SO; Guclu F; Hekimsoy Z
Eur Cytokine Netw; 2007 Sep; 18(3):148-53. PubMed ID: 17823083
[TBL] [Abstract][Full Text] [Related]
34. Is skeletal responsiveness to thyroid hormone altered in primary osteoporosis or following estrogen replacement therapy?
Langdahl BL; Loft AG; Møller N; Weeke J; Eriksen EF; Mosekilde L; Charles P
J Bone Miner Res; 1997 Jan; 12(1):78-88. PubMed ID: 9240729
[TBL] [Abstract][Full Text] [Related]
35. Serum levels of intact parathyroid hormone and alkaline phosphatase correlate with cortical and trabecular bone loss in primary hyperparathyroidism.
Pfeilschifter J; Siegrist E; Wüster C; Blind E; Ziegler R
Acta Endocrinol (Copenh); 1992 Oct; 127(4):319-23. PubMed ID: 1449043
[TBL] [Abstract][Full Text] [Related]
36. Changes of bone markers during long-term intravenous calcitriol therapy in maintenance dialysis patients.
Lee SH; Huang TS; Hsieh SJ
Miner Electrolyte Metab; 1996; 22(4):219-23. PubMed ID: 8807625
[TBL] [Abstract][Full Text] [Related]
37. A role for interleukin-6 in parathyroid hormone-induced bone resorption in vivo.
Grey A; Mitnick MA; Masiukiewicz U; Sun BH; Rudikoff S; Jilka RL; Manolagas SC; Insogna K
Endocrinology; 1999 Oct; 140(10):4683-90. PubMed ID: 10499526
[TBL] [Abstract][Full Text] [Related]
38. Circulating levels of inflammatory markers predict change in bone mineral density and resorption in older adults: a longitudinal study.
Ding C; Parameswaran V; Udayan R; Burgess J; Jones G
J Clin Endocrinol Metab; 2008 May; 93(5):1952-8. PubMed ID: 18285417
[TBL] [Abstract][Full Text] [Related]
39. Cross-sectional evaluation of bone metabolism in men.
Szulc P; Garnero P; Munoz F; Marchand F; Delmas PD
J Bone Miner Res; 2001 Sep; 16(9):1642-50. PubMed ID: 11547833
[TBL] [Abstract][Full Text] [Related]
40. Bone resorption activity of osteolytic metastatic lung and breast cancers.
Shih LY; Shih HN; Chen TH
J Orthop Res; 2004 Nov; 22(6):1161-7. PubMed ID: 15475192
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
